We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

University of Oxford Partners With AstraZeneca To Accelerate Globalization of COVID-19 Vaccine in Clinical Trials

News   Apr 30, 2020 | By Molly Campbell, Science Writer, Technology Networks

 
University of Oxford Partners With AstraZeneca To Accelerate Globalization of COVID-19 Vaccine in Clinical Trials
 
 
Advertisement
 

RELATED ARTICLES


Converting Autoimmunity Drugs Into Powerful Anticancer Treatments

News

A team from the University of Southampton has discovered a way to transform antibody drugs previously developed to treat autoimmunity into antibodies with powerful anti-cancer activity through a simple molecular “switch”.

READ MORE

Cell Culture Systems for Anticancer Drug Screening

News

A newly published paper provides an insight into in vitro based testing of anticancer drugs.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE